NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Gilberto Benetton, a founder of fashion brand, dies at 77

Oct 23, 2018

MILAN — Gilberto Benetton, one of the four founding siblings of the iconic Benetton fashion brand known as much for its provocative ad campaigns as its colorful knitwear, died Monday evening at age 77, his family announced. The family said Benetton's wife, Lalla, two daughters, Barbara and Sabrina, and son-in-law Ermanno were by his side at his home in the northern city of Treviso, near where the fashion company is based. The news agency ANSA said he had suffered an undisclosed illness. . Gilberto, along with siblings Carlo, Luciano and Giuliana, founded Benetton as knitwear company in 1965, transforming it...

Birth of a new Ukrainian church brings fears of violence

Oct 23, 2018

KIEV, Ukraine — The rough-looking young men brought clubs and brass knuckles to the Pechersk Monastery in Kiev , one of Orthodox Christianity's most important pilgrimage sites, apparently seeking to disrupt worship. Police spread-eagled them against a wall decorated in faded centuries-old frescos of solemn saints, then hauled them away. On the other side of the dispute, at a small church in the center of Kiev, a dozen men organized round-the-clock guard duty, worried that nationalist radicals might make their third attempt in a year to seize the place of worship. The incidents a week ago underline the tensions in...

Cyprus airline Cobalt halts flights amid lack of investment

Oct 23, 2018

NICOSIA, Cyprus — Cyprus-based airline Cobalt Air suspended its operations indefinitely after failing to find new investors to keep it in flight, officials said Thursday. As stranded passengers scrambled to find alternate flights, Cyprus' government said it would compensate Cobalt Air ticketholders who end up with other carriers to get to and from the Mediterranean island. The Cypriot transport ministry said in a statement that passengers would be compensated for one-way, economy class tickets on other carriers up until Oct. 24. Cypriot travel agencies Orthodoxou Travel and Top Kinisis were authorized to book return flights. "We feel the need to...

'Malnourished' animals report prompts Albania zoo closure

Oct 23, 2018

MBROSTAR, Albania — A report claiming lions and other animals were left malnourished at a private zoo in Albania has prompted Albanian authorities to order the zoo's temporary closure. Environment Minister Blendi Klosi ordered the immediate inspection and removal of the animals from the Safari Zoo Park resort following a report in Britain's Daily Mail Tuesday with photos showing a lion with an eye infection and other apparently malnourished animals in iron cages. But Ardjan Koci, a conservation official, said a recent inspection found all animals at the zoo in Mbrostar, 100 kilometers (60 miles) south of the capital Tirana,...

Basking in the Tuscan Sun

Oct 23, 2018

CORTONA, Italy — After my breast cancer diagnosis and as I was going through what would be more than a year of treatments that included chemotherapy and radiation, I vowed I would return to Italy. Both sets of my grandparents emigrated from there, and I always turned to Italy as a source of comfort. At first, I wasn't sure what part of Italy I would travel. The last time I was there was in 1998. But when my sister and brother-in-law invited me for a one-week stay at a villa in Cortona in Tuscany, I knew my plans were set....

Sign up now!

The Healthier Web delivers accurate and up-to-date health information through medical content and insights from experts. Feel the ‘ohm’ here in The Healthier Web.

Contact us: sales[at]thehealthierweb.com